CVE-2023-6260

HIGHCVSS 8.8/10EPSS 0.90%

Last modified

CVE-2023-6260 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') vulnerability in Brivo ACS100, ACS300 allows OS Command Injection, Bypassing Physical Security.This issue affects ACS100 (Network Adjacent Access), ACS300 (Physical Access): from 5.2.4 before 6.2.4.3. . EPSS estimates a 0.90% chance of exploitation in the next 30 days.

Description

Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') vulnerability in Brivo ACS100, ACS300 allows OS Command Injection, Bypassing Physical Security.This issue affects ACS100 (Network Adjacent Access), ACS300 (Physical Access): from 5.2.4 before 6.2.4.3.

Metrics

CVSS 3.1
8.8/10

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS Probability
0.90%

55.1th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
BrivoAcs100 Firmware>= 5.2.4, <= 6.2.4.3
BrivoAcs300 Firmware>= 5.2.4, < 6.2.4.3

References

Timeline

Published
Last Modified
Status
Analyzed

Frequently Asked Questions

What is CVE-2023-6260?
Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') vulnerability in Brivo ACS100, ACS300 allows OS Command Injection, Bypassing Physical Security.This issue affects ACS100 (Network Adjacent Access), ACS300 (Physical Access): from 5.2.4 before 6.2.4.3.
How severe is CVE-2023-6260?
CVE-2023-6260 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 0.90% probability of exploitation in the next 30 days.
How do I fix CVE-2023-6260?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-6260?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST